Ron Pirucki

Experience

• 

  US Army

  Jan 1987 - Jan 1989

  Combat Medical Specialist - U.S. Army, 3rd Armored Division, Kirchgoens, FRD
• 

  EP Technologies - Boston Scientific Corporation

  May 1995 - Aug 1998

  Senior Clinical Specialist
• 

  Boston Scientific

  Jan 2000 - Jan 2002

  Senior Product Manager - Cardiac Pathways, Corp.
• 

  Intraluminal Therapeutics

  Aug 2002 - Aug 2005

  Region Sales Manager

  In this role, I directed robust sales and marketing efforts in APAC and the US, leading to significant market expansion and a successful acquisition by Kensey Nash in 2005.Key Achievements:➣ Managed successful product launches and strategic sales initiatives that expanded market presence and significantly boosted company revenues.➣ Recognized for outstanding sales performance; propelled company to achieve rapid growth, leading to its acquisition by Kensey Nash.➣ Developed and executed innovative sales strategies that effectively addressed diverse market dynamics and customer needs. Show less

• 

  Biosense Webster

  Aug 2005 - May 2008

  Global Group Product Director - AFIB/VT

  In this role, I spearheaded the global launch and adoption of pioneering electrophysiology products, significantly enhancing the company’s market presence and revenue.Key Achievements:➣ Led the successful launch of the PentaRay™ Catheter and CFAE Software™, achieving $50M in annual revenue by 2008.➣ Played a crucial role in strategic product planning and global market expansion, contributing to substantial revenue growth.➣ Engaged with key opinion leaders worldwide to foster strong partnerships and enhance product visibility and adoption. Show less

• 

  ScottCare Corporation

  Jun 2008 - Feb 2009

  Director, Sales and Marketing

  In this role, I directed ScottCare Corporation's post-acquisition integration and marketing strategies, optimized operations, and reduced costs.Key Achievements:➣ Successfully merged three distinct sales and customer service teams into a cohesive unit, enhancing operational efficiency and market responsiveness.➣ Implemented a comprehensive rebranding initiative, aligning all acquired entities under the ScottCare brand to solidify market presence.➣ Spearheaded the marketing overhaul, significantly enhancing brand visibility and streamlining marketing efforts across the board. Show less

• 

  Terumo Medical Corporation

  Jan 2010 - Dec 2014

  In this role, I guided the company through significant rebranding and market repositioning, leading to the successful launch and market adoption of the SoloPath™ product line.Key Achievements:➣ Instrumental in redefining product strategies from kidney stone treatment to cardiovascular applications, increasing market share and product viability.➣ Managed the launch and rapid market penetration of SoloPath™, achieving over $1M in revenues in its first year.➣ Facilitated Onset Medical's $18M acquisition by Terumo through strategic marketing and robust sales performance. Show less

  • Director of Global Marketing Manager

    Jan 2011 - Dec 2014

  • Director of Clinical Marketing - Formally Onset Medical Corporation

    Jan 2009 - Jan 2014

  • Director, Global Sales and Marketing - Onset Medical Corp. Acquired by Terumo 2011

    Jan 2010 - Jan 2011
• 

  Obalon Therapeutics

  Jan 2015 - Jan 2016

  Senior Field Clinical Engineer

  In this role, I advanced the Obalon Balloon System through pivotal U.S. PMA clinical trials and supported Obalon's successful NASDAQ IPO.Key Achievements:➣ Led critical operations for the SMART-CAR study, expediting patient enrollment and data collection.➣ Supported in transitioning Obalon from a private entity to a public company, enhancing valuation through rigorous clinical trial management.➣ Managed site operations and regulatory compliance, ensuring the success of clinical objectives. Show less

• 

  Boston Scientific

  Jan 2017 - Jan 2019

  Regional Manager – Western US - Claret Medical

  In this role, I led the launch and commercial activities of the Sentinel™ Cerebral Embolic Protection System in the Western US and also contributed to the company’s acquisition by Boston Scientific Corporation in 2018.Key Achievements:➣ Achieved a $25M run rate and 20% market penetration swiftly post-product launch.➣ Played a key role in the $270M acquisition of Claret Medical by Boston Scientific within 18 months of the product launch.➣ Surpassed regional sales targets, increasing quarterly sales by 20% for five consecutive quarters, and built a robust annual revenue stream. Show less

• 

  BioVentrix

  Jan 2020 - Jan 2023

  Manager, Clinical Field Operations

  In this role, I revitalized and led the ALIVE study, overcame significant delays, and completed critical clinical trials focused on left ventricular enhancement within 18 months.Key Achievements:➣ Directed the turnaround of the ALIVE Study, significantly boosting patient recruitment and operational efficiency.➣ Achieved study compliance and managed clinical teams across the Western US, ensuring adherence to GCP and MDD standards.➣ Streamlined patient data integrity and trial objectives in collaboration with the Image Review Committee for timely study completion. Show less

• 

  Pi-Cardia

  Jan 2023 - now

  Senior Manager, Global Therapy Development

  In this role, I steered the ShortCut™ study, surpassed enrollment targets, and streamlined the FDA submission process while setting the stage for rapid commercialization.Key Achievements:➣ Exceeded enrollment targets three months ahead of schedule through effective site management and clinical oversight.➣ Facilitated rapid FDA submission, contributing to FDA breakthrough designation.➣ Prepared Pi-Cardia's ShortCut™ study for successful commercialization by spearheading cross-functional team collaborations across the US, Israel, and Europe. Show less